A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer.
Looking at options history for Pfizer PFE we detected 37 strange trades.
If we consider the specifics of each trade, it is accurate to state that 54% of the investors opened trades with bullish expectations and 45% with bearish.
From the overall spotted trades, 10 are puts, for a total amount of $1,240,217 and 27, calls, for a total amount of $1,715,211.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $65.0 for Pfizer over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Pfizer's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale activity within a strike price range from $20.0 to $65.0 in the last 30 days.
Pfizer Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| PFE | PUT | TRADE | BEARISH | 01/20/23 | $55.00 | $700.0K | 14.3K | 1.0K |
| PFE | CALL | TRADE | BULLISH | 01/21/22 | $49.00 | $345.0K | 23.3K | 1.0K |
| PFE | CALL | TRADE | BULLISH | 01/21/22 | $49.00 | $258.0K | 23.3K | 502 |
| PFE | CALL | SWEEP | BULLISH | 06/17/22 | $50.00 | $153.0K | 34.3K | 316 |
| PFE | PUT | SWEEP | BULLISH | 02/18/22 | $50.00 | $85.3K | 11.5K | 2.0K |
Where Is Pfizer Standing Right Now?
- With a volume of 25,408,415, the price of PFE is up 0.71% at $56.12.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 29 days.
What The Experts Say On Pfizer:
- UBS upgraded its action to Buy with a price target of $60
- Mizuho has decided to maintain their Neutral rating on Pfizer, which currently sits at a price target of $56.
- SVB Leerink has decided to maintain their Market Perform rating on Pfizer, which currently sits at a price target of $56.
- B of A Securities upgraded its action to Buy with a price target of $70
- Goldman Sachs downgraded its action to Neutral with a price target of $51
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
